Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MS › Oxford › NPI 1053375576
Hospital

Baptist Memorial Hospital North Mississippi, INC

Baptist Memorial Hospital North Mississippi, INC was paid $38.92M by Medicaid between Jan 2018 and Dec 2024, across 354 billing codes. Its largest line is 99284, emergency room visit (serious) — 13% of everything it billed.

33Billing provider infoBAPTIST MEMORIAL HOSPITAL NORTH MISSISSIPPI, INC
OXFORD, MS 38655
33aNPI1053375576assigned 04/13/2006
28Total paid$38.92M
24GClaims1,165,362
24DCodes billed354
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Mississippi

Rank by total paid#11 of 77
Median peer was paid$8.23M
This provider vs. median4.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official DUCKETT, GREGORY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018182,403$6.23M
2019196,799$5.85M
2020158,414$5.36M
2021165,450$5.32M
2022170,037$5.12M
2023167,334$6.03M
2024incomplete124,925$5.03M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 13% 28,272 23,017 $5.16M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 8.5% 23,918 20,131 $3.29M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 8.3% 16,676 13,600 $3.24M
G0378 Hospital observation service, per hour 6.4% 8,246 5,229 $2.49M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.3% 17,175 13,426 $1.28M
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 2.7% 3,405 2,973 $1.05M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.7% 6,982 5,637 $1.04M
J9271 Injection, pembrolizumab, 1 mg 2.1% 288 160 $836K
D2930 Prefabricated stainless steel crown - primary tooth 2.1% 16,136 2,237 $808K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 2.1% 7,278 3,041 $805K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.0% 9,068 7,971 $789K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.9% 2,292 1,962 $746K
342 more codes
71045 Radiologic examination, chest; single view 1.8% 20,623 $690K
D0272 Bitewings - two radiographic images 1.8% 961 $687K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.7% 4,573 $663K
96361 Intravenous infusion, hydration; each additional hour 1.6% 11,723 $625K
D7140 Extraction, erupted tooth or exposed root 1.6% 1,809 $618K
J2505 Injection, pegfilgrastim, 6 mg 1.6% 527 $613K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1.4% 7,133 $551K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.3% 19,221 $514K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.1% 6,002 $429K
78815 Positron emission tomography (PET) for limited area imaging 1.1% 1,430 $421K
J0897 Injection, denosumab, 1 mg 1.1% 1,026 $409K
93458 1.0% 550 $407K
96375 Therapeutic injection; each additional sequential IV push 1.0% 18,178 $394K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 22,591 $387K
80053 Comprehensive metabolic panel <1% 53,548 $341K
71046 Radiologic examination, chest; 2 views <1% 7,943 $338K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 7,274 $338K
70450 Computed tomography, head or brain; without contrast material <1% 7,724 $328K
D2934 <1% 4,850 $320K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 64,021 $268K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 6,280 $259K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 9,377 $256K
99214 Doctor's office visit, returning patient (more involved) <1% 9,345 $246K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 9,108 $241K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 19,445 $232K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,603 $226K
D3330 Endodontic therapy, molar tooth (excluding final restoration) <1% 1,336 $224K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 2,801 $222K
36415 Collection of venous blood by venipuncture <1% 78,896 $177K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,611 $172K
93017 <1% 2,544 $167K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 12,689 $165K
71275 Computed tomographic angiography, chest, with contrast material <1% 2,118 $154K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 2,736 $152K
86900 <1% 3,641 $151K
D3220 Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction <1% 4,341 $146K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,552 $135K
D3320 <1% 384 $128K
D3310 <1% 972 $127K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,185 $127K
83880 <1% 6,426 $125K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 3,164 $125K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 649 $122K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,242 $121K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 6,157 $119K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 747 $117K
99213 Doctor's office visit, returning patient (routine) <1% 4,123 $114K
J2469 Injection, palonosetron hcl, 25 mcg <1% 2,126 $113K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,356 $106K
84484 <1% 17,793 $106K
73560 <1% 2,765 $97K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 14,387 $88K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 440 $84K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,892 $74K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,126 $73K
81001 <1% 29,244 $70K
72125 Computed tomography, cervical spine; without contrast material <1% 2,018 $69K
73630 <1% 1,782 $68K
86901 <1% 4,542 $63K
73610 <1% 1,456 $61K
80048 Basic metabolic panel (calcium, ionized) <1% 12,128 $60K
86850 <1% 3,080 $56K
73130 <1% 1,393 $56K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 8,239 $54K
93971 <1% 1,435 $53K
84443 Thyroid stimulating hormone (TSH) <1% 5,440 $52K
83735 <1% 14,487 $51K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 798 $51K
85027 <1% 13,411 $47K
73030 <1% 1,479 $46K
72100 <1% 931 $44K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,893 $42K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,008 $42K
87086 Culture, bacterial; quantitative colony count, urine <1% 8,241 $42K
77336 <1% 850 $42K
76000 <1% 411 $40K
D1120 Dental cleaning, child <1% 3,042 $39K
81025 <1% 6,403 $38K
73502 <1% 1,339 $38K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,389 $38K
87040 <1% 8,139 $38K
96367 <1% 1,666 $37K
83690 <1% 8,585 $36K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 584 $35K
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units <1% 514 $34K
70486 <1% 470 $34K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,442 $33K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,442 $33K
84702 <1% 3,083 $32K
41899 Unlisted procedure, dentoalveolar structures <1% 201 $31K
72131 <1% 902 $30K
97162 <1% 1,016 $30K
83605 <1% 6,192 $29K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 296 $29K
J0185 Injection, aprepitant, 1 mg <1% 361 $28K
D1208 Topical application of fluoride, excluding varnish <1% 3,041 $28K
74018 <1% 589 $28K
96417 <1% 1,182 $27K
96415 <1% 619 $25K
84703 <1% 5,216 $25K
87807 <1% 2,283 $25K
85610 <1% 11,577 $25K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 168 $24K
36430 <1% 252 $23K
85730 <1% 7,026 $22K
77067 Screening mammography, bilateral, including computer-aided detection <1% 282 $22K
76801 <1% 311 $22K
80061 Lipid panel <1% 2,864 $22K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,325 $22K
97602 <1% 296 $18K
99204 Doctor's office visit, new patient (more involved) <1% 351 $18K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 55 $17K
36600 <1% 612 $16K
71250 <1% 377 $15K
73590 <1% 396 $15K
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) <1% 50 $15K
86160 <1% 2,371 $15K
86923 <1% 438 $14K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 830 $14K
P9016 Red blood cells, leukocytes reduced, each unit <1% 209 $14K
82728 <1% 1,995 $13K
Q3014 Telehealth originating site facility fee <1% 2,109 $13K
86140 <1% 4,493 $13K
D2391 Resin-based composite - one surface, posterior, primary or permanent <1% 677 $13K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 657 $12K
83036 Hemoglobin; glycosylated (A1C) <1% 2,318 $12K
85379 <1% 1,952 $12K
96411 <1% 579 $12K
82803 <1% 754 $11K
96416 <1% 105 $10K
97533 <1% 217 $10K
74019 <1% 143 $10K
82378 <1% 1,448 $10K
74022 <1% 163 $10K
82607 <1% 1,398 $9K
85007 <1% 3,677 $9K
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units <1% 565 $9K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 412 $8K
97166 <1% 245 $8K
72170 <1% 177 $8K
C9463 Injection, aprepitant, 1 mg <1% 48 $8K
74178 <1% 61 $8K
82565 <1% 2,474 $7K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 37 $7K
87070 <1% 1,343 $7K
83550 <1% 1,764 $7K
73090 <1% 171 $6K
85652 <1% 4,186 $6K
94726 <1% 90 $6K
80074 <1% 214 $6K
70551 Magnetic resonance imaging, brain; without contrast material <1% 80 $6K
82375 <1% 705 $6K
99215 Doctor's office visit, returning patient (complex) <1% 181 $6K
96377 <1% 557 $5K
83540 <1% 1,856 $5K
J7050 Infusion, normal saline solution, 250 cc <1% 9,644 $5K
A9270 Non-covered item or service <1% 12,348 $5K
86038 <1% 651 $4K
84439 <1% 823 $4K
82570 <1% 1,506 $4K
92523 <1% 31 $4K
87205 <1% 1,632 $4K
73070 <1% 111 $4K
73100 <1% 96 $4K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 23 $4K
85014 <1% 2,542 $4K
86003 <1% 1,451 $4K
84132 <1% 1,401 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 157 $3K
82550 <1% 961 $3K
77334 <1% 23 $3K
J1453 Injection, fosaprepitant, 1 mg <1% 24 $3K
84156 <1% 1,644 $3K
86300 <1% 552 $3K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 1,518 $3K
83050 <1% 693 $3K
97597 <1% 54 $3K
72128 <1% 118 $3K
82746 <1% 659 $3K
87797 <1% 154 $3K
83883 <1% 934 $3K
87480 <1% 123 $3K
77065 Tomosynthesis, mammo <1% 51 $3K
70496 <1% 54 $3K
85045 <1% 1,316 $3K
88342 <1% 30 $3K
72141 <1% 27 $2K
73552 <1% 75 $2K
87510 <1% 173 $2K
43235 <1% 15 $2K
83615 <1% 806 $2K
J7030 Infusion, normal saline solution , 1000 cc <1% 19,543 $2K
70498 <1% 53 $2K
83516 <1% 323 $2K
86235 <1% 283 $2K
J0640 Injection, leucovorin calcium, per 50 mg <1% 187 $2K
84165 <1% 821 $2K
84550 <1% 732 $2K
85018 <1% 1,066 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 32 $2K
84100 <1% 669 $2K
J9045 Injection, carboplatin, 50 mg <1% 188 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 24,596 $1K
80069 <1% 349 $1K
J9190 Injection, fluorouracil, 500 mg <1% 555 $1K
72110 <1% 41 $1K
92526 <1% 29 $1K
97116 <1% 83 $1K
73060 <1% 50 $1K
96376 <1% 4,852 $1K
10060 <1% 14 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 15,062 $1K
76641 <1% 24 $1K
86431 <1% 339 $1K
J9263 Injection, oxaliplatin, 0.5 mg <1% 69 $976.32
96523 <1% 44 $945.62
76830 Ultrasound, transvaginal <1% 15 $882.58
D2330 <1% 99 $877.94
71271 <1% 15 $876.28
D0220 Intraoral - periapical first radiographic image <1% 944 $869.84
76536 <1% 13 $857.10
97163 <1% 31 $823.72
97161 <1% 44 $813.66
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 57 $787.20
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 15,971 $786.74
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 846 $759.09
75635 <1% 14 $744.16
72050 <1% 17 $720.83
86480 <1% 44 $695.53
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 3,911 $694.42
87493 <1% 26 $682.58
D0230 Intraoral - periapical each additional radiographic image <1% 690 $664.97
0012A <1% 25 $661.43
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 5,842 $650.21
71101 <1% 14 $600.82
93880 <1% 15 $600.43
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,660 $576.30
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 2,339 $522.39
82140 <1% 98 $513.17
74230 <1% 18 $464.86
86200 <1% 100 $457.59
87340 <1% 118 $455.50
72040 <1% 13 $443.24
0011A <1% 25 $414.86
82784 <1% 138 $360.70
90686 <1% 77 $359.82
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 2,387 $349.75
86225 <1% 55 $348.93
94760 <1% 2,992 $337.72
99442 <1% 14 $328.75
C1769 Guide wire <1% 2,835 $319.01
80164 <1% 29 $296.56
88304 <1% 13 $272.23
99443 <1% 54 $253.88
J2785 Injection, regadenoson, 0.1 mg <1% 2,148 $237.02
84155 <1% 195 $222.86
82785 <1% 17 $202.62
J9267 Injection, paclitaxel, 1 mg <1% 41 $174.26
92611 <1% 18 $148.50
J0690 Injection, cefazolin sodium, 500 mg <1% 7,916 $143.41
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 11,851 $133.11
96402 <1% 23 $133.03
J3010 Injection, fentanyl citrate, 0.1 mg <1% 7,469 $118.56
D1206 Topical application of fluoride varnish <1% 34 $112.74
86780 <1% 13 $95.72
J8540 Dexamethasone, oral, 0.25 mg <1% 181 $90.70
C9113 Injection, pantoprazole sodium, per vial <1% 1,204 $90.13
J7120 Ringers lactate infusion, up to 1000 cc <1% 8,193 $88.09
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 203 $67.33
86334 <1% 15 $67.05
86308 <1% 13 $66.81
J2704 Injection, propofol, 10 mg <1% 13,234 $63.15
99201 <1% 27 $58.98
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,972 $49.10
86706 <1% 13 $48.55
J3370 Injection, vancomycin hcl, 500 mg <1% 360 $46.88
82248 <1% 17 $45.71
36416 <1% 471 $43.05
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 1,853 $41.46
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 670 $41.42
J1170 Injection, hydromorphone, up to 4 mg <1% 5,628 $40.26
J2270 Injection, morphine sulfate, up to 10 mg <1% 7,162 $37.27
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 5,215 $31.10
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,468 $27.69
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 8,192 $27.39
J2550 Injection, promethazine hcl, up to 50 mg <1% 2,047 $27.13
36592 <1% 40 $20.72
J1650 Injection, enoxaparin sodium, 10 mg <1% 4,899 $20.24
J3480 Injection, potassium chloride, per 2 meq <1% 146 $19.77
J3475 Injection, magnesium sulfate, per 500 mg <1% 233 $16.67
84145 <1% 4,026 $14.29
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 38 $10.47
A9609 Fludeoxyglucose f18 up to 15 millicuries <1% 96 $7.89
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 2,815 $7.09
J2060 Injection, lorazepam, 2 mg <1% 287 $6.50
J0360 Injection, hydralazine hcl, up to 20 mg <1% 1,426 $5.85
J1940 Injection, furosemide, up to 20 mg <1% 758 $1.92
G0008 Administration of influenza virus vaccine <1% 62 $1.29
96368 <1% 318 $1.28
J1644 Injection, heparin sodium, per 1000 units <1% 3,175 $0.54
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 441 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 112 $0.00
94729 0% 89 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 37 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 172 $0.00
93356 0% 178 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 221 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 188 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 89 $0.00
J1956 Injection, levofloxacin, 250 mg 0% 214 $0.00
J7510 Prednisolone oral, per 5 mg 0% 33 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 64 $0.00
77012 0% 62 $0.00
76942 0% 163 $0.00
90715 0% 29 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 130 $0.00
G8997 Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 34 $0.00
G8996 Swallowing functional limitation, current status at therapy episode outset and at reporting intervals 0% 33 $0.00
C1776 Joint device (implantable) 0% 19 $0.00
J1643 Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units 0% 44 $0.00
76937 0% 22 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 1,881 $0.00
J2175 Injection, meperidine hydrochloride, per 100 mg 0% 534 $0.00
C9290 Injection, bupivacaine liposome, 1 mg 0% 1,018 $0.00
J3490 Unclassified drugs 0% 603 $0.00
J2780 Injection, ranitidine hydrochloride, 25 mg 0% 896 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 758 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 1,787 $0.00
J2360 Injection, orphenadrine citrate, up to 60 mg 0% 1,646 $0.00
80050 General health panel 0% 102 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 484 $0.00
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 0% 159 $0.00
77063 Screening digital breast tomosynthesis, bilateral 0% 52 $0.00
J7060 5% dextrose/water (500 ml = 1 unit) 0% 205 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 607 $0.00
C1781 Mesh (implantable) 0% 42 $0.00
0352U 0% 178 $0.00
80349 0% 29 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 18 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 48 $0.00
G8998 Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting 0% 18 $0.00
G0379 Direct admission of patient for hospital observation care 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDUCKETT, GREGORY (SR VP/CLO)
Parent organizationBAPTIST MEMORIAL HEALTH CARE CORP.
Same official

Other billing entities under DUCKETT, GREGORY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.